-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
ADC Therapeutics SA quarterly and annual Revenues in USD history and change rate from 31 Dec 2022 to 31 Dec 2025.
- ADC Therapeutics SA Revenues for the quarter ending 31 Dec 2025 was $23,058,000, a 36% increase year-over-year.
- ADC Therapeutics SA Revenues for the twelve months ending 31 Dec 2025 was $81,357,000, a 15% increase year-over-year.
- ADC Therapeutics SA annual Revenues for 2025 was $81,357,000, a 15% increase from 2024.
- ADC Therapeutics SA annual Revenues for 2024 was $70,837,000, a 1.8% increase from 2023.
- ADC Therapeutics SA annual Revenues for 2023 was $69,558,000, a 67% decline from 2022.